Inflammasome inhibitors - Development of new inhibitors
Inhibition of the Inflammasome, a high-molecular complex, is a promising strategy to fight certain diseases with an (auto-)immune component, including gout, arthritis, Alzheimer's and Parkinson's.
Description
Inhibition of the Inflammasome is a promising strategy to fight certain diseases with an (auto-)immune component, including gout, arthritis, Alzheimer's and Parkinson's. We will develop, optimize and validate one or several new Inflammasome inhibitors, starting from an existing set of lead molecules.
Key Data
Projectlead
Project team
Project partners
Universität Basel / Biozentrum; Université de Lausanne
Project status
completed, 06/2020 - 04/2022
Funding partner
Innosuisse - Innovationsprojekt
Project budget
477'000 CHF
Einsiedlerstrasse 31
8820 Wädenswil